Rh30 (Q54950341)

27 January 2023

1 reference

A specific chromosomal abnormality in rhabdomyosarcoma.

27 January 2023

1 reference

27 January 2023

Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.

1 reference

27 January 2023

Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.

1 reference

27 January 2023

Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3.

1 reference

27 January 2023

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development

1 reference

27 January 2023

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

1 reference

27 January 2023

National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing

1 reference

27 January 2023

Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis

1 reference

27 January 2023

Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways

1 reference

27 January 2023

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

27 January 2023

Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array

1 reference

27 January 2023

Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls

1 reference

27 January 2023

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

27 January 2023

Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status

1 reference

27 January 2023

Sarcoma Cell Line Screen of Oncology Drugs and Investigational Agents Identifies Patterns Associated with Gene and microRNA Expression

1 reference

27 January 2023

A landscape of pharmacogenomic interactions in cancer.

1 reference

27 January 2023

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

27 January 2023

Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization

1 reference

27 January 2023

Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis

1 reference

27 January 2023

Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A.

1 reference

27 January 2023

Signatures of mutation and selection in the cancer genome

1 reference

27 January 2023

Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.

1 reference

27 January 2023

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

27 January 2023

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

27 January 2023

Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling

1 reference

27 January 2023

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

27 January 2023

Amplification of the gli gene in childhood sarcomas.

1 reference

27 January 2023

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

1 reference

27 January 2023

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

1 reference

27 January 2023

Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro

1 reference

27 January 2023

The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway

1 reference

27 January 2023

Assessing alveolar rhabdomyosarcoma cell lines as tumor models by comparison of mRNA expression profiles

1 reference

27 January 2023

Bax is an important determinant of chemosensitivity in pediatric tumor cell lines independent of Bcl-2 expression and p53 status.

1 reference

27 January 2023

established from medical condition

alveolar rhabdomyosarcoma

1 reference

27 January 2023

derived from organism type

1 reference

http://purl.obolibrary.org/obo/BTO_0005379

27 January 2023

1 reference

27 January 2023

http://purl.obolibrary.org/obo/EFO_0002329

1 reference

27 January 2023

http://purl.obolibrary.org/obo/EFO_0005722

1 reference

27 January 2023

http://purl.obolibrary.org/obo/CLO_0009030

1 reference

27 January 2023

Identifiers

Cell Line Ontology ID

CLO_0009030

1 reference

27 January 2023

1 reference

27 January 2023